Literature DB >> 26581161

SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.

Tianming Li1, Qidi Zheng1, Jiahui An1, Mengying Wu1, Haiyan Li1, Xin Gui1, Hu Pu1, Dongdong Lu2.   

Abstract

Long noncoding RNA CUDR plays an important role during tumorigenesis. Herein, we demonstrate that SET1A cooperates with CUDR to accelerate hepatocarcinogenesis and promote malignant transformation of hepatocyte-like stem cells. Mechanistically, CUDR enhances the phosphorylation of RB1, C-myc expression, and the interplay between the SET1A and pRB1. Notably, CUDR acts as a sponge cushion that shows a link between SET1A and pRB1, producing a activated pRB1-SET1A complex. On the other hand, the pRB1-SET1A complex may carry methyls(me) to occupy the position of H3K4, resulting in specific tri-methylation of forth lysine of histone H3 (H3K4me3). Thereby, the H3K4me3 loads on the TRF2 promoter region which causes the TRF2 overexpression. Ultimately, the excessive TRF2 binds to telomere repeat DNA, prolonging the telomere length. These findings provide the first demonstration that SET1A cooperates with CUDR to play a positive potential role during hepatocarcinogenesis and hepatocyte-like stem cells' malignant transformation epigenetically.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26581161      PMCID: PMC4817816          DOI: 10.1038/mt.2015.208

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  60 in total

Review 1.  Unsafe SETs: histone lysine methyltransferases and cancer.

Authors:  Robert Schneider; Andrew J Bannister; Tony Kouzarides
Journal:  Trends Biochem Sci       Date:  2002-08       Impact factor: 13.807

2.  Differentiation of mouse and human embryonic stem cells into hepatic lineages.

Authors:  Nobuaki Shiraki; Kahoko Umeda; Naomi Sakashita; Motohiro Takeya; Kazuhiko Kume; Shoen Kume
Journal:  Genes Cells       Date:  2008-05-30       Impact factor: 1.891

3.  RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.

Authors:  Jussara Hagen; Viviane P Muniz; Kelly C Falls; Sara M Reed; Agshin F Taghiyev; Frederick W Quelle; Francoise A Gourronc; Aloysius J Klingelhutz; Heather J Major; Ryan W Askeland; Scott K Sherman; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe; Benjamin W Darbro; Dawn E Quelle
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

4.  Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.

Authors:  M Pontoglio; J Barra; M Hadchouel; A Doyen; C Kress; J P Bach; C Babinet; M Yaniv
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

5.  Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.

Authors:  Wing Pui Tsang; Timothy W L Wong; Albert H H Cheung; Chloe N N Co; Tim Tak Kwok
Journal:  RNA       Date:  2007-04-06       Impact factor: 4.942

6.  Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.

Authors:  Fereshteh Parviz; Christine Matullo; Wendy D Garrison; Laura Savatski; John W Adamson; Gang Ning; Klaus H Kaestner; Jennifer M Rossi; Kenneth S Zaret; Stephen A Duncan
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

7.  Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.

Authors:  Yu Wang; Wei Chen; Chen Yang; Wenjing Wu; Shouzhen Wu; Xuebin Qin; Xu Li
Journal:  Int J Oncol       Date:  2012-04-20       Impact factor: 5.650

8.  Multifaceted genome control by Set1 Dependent and Independent of H3K4 methylation and the Set1C/COMPASS complex.

Authors:  Irina V Mikheyeva; Patrick J R Grady; Fiona B Tamburini; David R Lorenz; Hugh P Cam
Journal:  PLoS Genet       Date:  2014-10-30       Impact factor: 5.917

9.  MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.

Authors:  Fengmei Shen; Meng-Hsuan Mo; Liang Chen; Shejuan An; Xiaohui Tan; Yebo Fu; Katayoon Rezaei; Zuoren Wang; Lin Zhang; Sidney W Fu
Journal:  J Cancer       Date:  2014-11-21       Impact factor: 4.207

10.  TRF2 and lamin A/C interact to facilitate the functional organization of chromosome ends.

Authors:  Ashley M Wood; Jannie M Rendtlew Danielsen; Catherine A Lucas; Ellen L Rice; David Scalzo; Takeshi Shimi; Robert D Goldman; Erica D Smith; Michelle M Le Beau; Steven T Kosak
Journal:  Nat Commun       Date:  2014-11-17       Impact factor: 14.919

View more
  27 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 3.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 4.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

5.  MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.

Authors:  Yuxin Yang; Qiuyu Meng; Chen Wang; Xiaonan Li; Yanan Lu; Xiaoru Xin; Qidi Zheng; Dongdong Lu
Journal:  J Mol Med (Berl)       Date:  2018-08-23       Impact factor: 4.599

6.  HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.

Authors:  Mengying Wu; Zhuojia Lin; Xiaonan Li; Xiaoru Xin; Jiahui An; Qidi Zheng; Yuxin Yang; Dongdong Lu
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

Review 7.  LncRNAs and their role in cancer stem cells.

Authors:  Shusen Chen; Jiamin Zhu; Feng Wang; Zhifeng Guan; Yangyang Ge; Xi Yang; Jing Cai
Journal:  Oncotarget       Date:  2017-10-30

8.  Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.

Authors:  Yao-Fei Pei; Ya-Jing Zhang; Yao Lei; Wei-ding Wu; Tong-Hui Ma; Xi-Qiang Liu
Journal:  Oncotarget       Date:  2017-04-04

9.  Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.

Authors:  Mengying Wu; Jiahui An; Qidi Zheng; Xiaoru Xin; Zhuojia Lin; Xiaonan Li; Haiyan Li; Dongdong Lu
Journal:  Oncotarget       Date:  2016-10-11

Review 10.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Authors:  Richard Heery; Stephen P Finn; Sinead Cuffe; Steven G Gray
Journal:  Cancers (Basel)       Date:  2017-04-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.